A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects-Reference-Cited by-同舟云学术

A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects

Published:2016-03 Issue:3 Volume:23 Page:427-440
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Talukdar Saswata,Zhou Yingjiang,Li Dongmei,Rossulek Michelle,Dong Jennifer,Somayaji Veena,Weng Yan,Clark Ronald,Lanba Adhiraj,Owen Bryn M.,Brenner Martin B.,Trimmer Jeffrey K.,Gropp Kathryn E.,Chabot Jeffrey R.,Erion Derek M.,Rolph Timothy P.,Goodwin Bryan,Calle Roberto A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference41 articles.

1. Fundamentals of FGF19 & FGF21 action in vitro and in vivo;Adams;PLoS ONE,2012

2. LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys;Adams;PLoS ONE,2013

3. FGF21 regulates metabolism and circadian behavior by acting on the nervous system;Bookout;Nat. Med.,2013

4. Weight loss-induced changes in adipose tissue proteins associated with fatty acid and glucose metabolism correlate with adaptations in energy expenditure;Camps;Nutr. Metab. (Lond),2015

5. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism;Ding;Cell Metab.,2012

Cited by 405 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-aided engineering of stabilized fibroblast growth factor 21;Computational and Structural Biotechnology Journal;2024-12

2. Endocrine fibroblast growth factors in domestic animals;Domestic Animal Endocrinology;2024-10

3. FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond;Journal of Hepatology;2024-09

4. Emerging role of liver-bone axis in osteoporosis;Journal of Orthopaedic Translation;2024-09

5. Fibroblast growth factor 21;Differentiation;2024-09